• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸法舒地尔水合物,一种 Rho 激酶抑制剂,通过 JNK 和 ERK1/2 通路抑制异丙肾上腺素诱导的大鼠心力衰竭。

Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.

机构信息

Department of Pharmacology, School of Basic Medicine, Heibei Medical University, Shijiazhuang 050091, Hebei, China.

出版信息

J Cell Biochem. 2011 Jul;112(7):1920-9. doi: 10.1002/jcb.23112.

DOI:10.1002/jcb.23112
PMID:21433064
Abstract

The Rho-kinase (ROCK) plays an important role in the pathogenesis of heart injury. Recent cellular and molecular biology studies indicated a pivotal role of the RhoA/ROCK cascade in many aspects of cardiovascular function such as heart failure, cardiac hypertrophy, and ventricular remodeling following myocardial infarction. However, the signal transduction of RhoA/ROCK and its down-stream signaling pathways remains elusive, and the mechanism of ROCK-mediated isoproterenol (ISO)-induced heart failure is still not thoroughly understood. In the present study, we investigated the effect of the ROCK inhibitor, fasudil hydrochloride hydrate, on ISO-induced heart failure and the potential relationship of RhoA/ROCK to the extracellular signal-regulated kinases (ERK) and the c-jun NH 2-terminal kinase (JNK) pathways. Male Sprague-Dawley (SD) rats, maintained on a normal diet, were randomly divided into four groups given control, ISO alone, ISO with low-dose fasudil, or ISO with high-dose fasudil treatments. Fasudil effectively inhibited ISO-induced heart failure, as evaluated by biometric, hemodynamic, and histological examinations. Consistently, ISO-induced ROCK-1 mRNA expression and myosin phosphatase target subunit-1 (MYPT-1) phosphorylation were markedly suppressed by fasudil. In addition, fasudil significantly decreased ISO-induced JNK activation, ERK translocation to the nucleus and subsequent c-fos, c-jun expression and upregulated c-FLIP(L) expression. Taken together, these results indicate that the RhoA/ROCK pathway is essential for ISO induced heart failure, which can be effectively suppressed by fasudil.

摘要

Rho 激酶(ROCK)在心脏损伤的发病机制中起重要作用。最近的细胞和分子生物学研究表明,RhoA/ROCK 级联在心力衰竭、心肌梗死后的心脏肥大和心室重构等许多心血管功能方面起着关键作用。然而,RhoA/ROCK 的信号转导及其下游信号通路仍不清楚,ROCK 介导的异丙肾上腺素(ISO)诱导的心力衰竭的机制仍未完全阐明。在本研究中,我们研究了 ROCK 抑制剂盐酸法舒地尔对 ISO 诱导的心力衰竭的影响,以及 RhoA/ROCK 与细胞外信号调节激酶(ERK)和 c-jun NH2 末端激酶(JNK)途径的潜在关系。雄性 Sprague-Dawley(SD)大鼠在正常饮食下饲养,随机分为四组,分别给予对照、ISO 单独处理、ISO 与低剂量法舒地尔或 ISO 与高剂量法舒地尔处理。法舒地尔有效抑制了生物计量学、血液动力学和组织学检查评估的 ISO 诱导的心力衰竭。一致地,法舒地尔明显抑制了 ISO 诱导的 ROCK-1 mRNA 表达和肌球蛋白磷酸酶靶亚单位-1(MYPT-1)磷酸化。此外,法舒地尔显著降低了 ISO 诱导的 JNK 激活、ERK 向核内转移以及随后的 c-fos、c-jun 表达,并上调了 c-FLIP(L)表达。总之,这些结果表明,RhoA/ROCK 途径对于 ISO 诱导的心力衰竭是必不可少的,法舒地尔可以有效地抑制其发生。

相似文献

1
Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.盐酸法舒地尔水合物,一种 Rho 激酶抑制剂,通过 JNK 和 ERK1/2 通路抑制异丙肾上腺素诱导的大鼠心力衰竭。
J Cell Biochem. 2011 Jul;112(7):1920-9. doi: 10.1002/jcb.23112.
2
Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.盐酸法舒地尔水合物,一种Rho激酶抑制剂,通过JNK和ERK1/2信号通路抑制5-羟色胺诱导的肺动脉平滑肌细胞增殖。
Pharmacology. 2009;83(2):67-79. doi: 10.1159/000178814. Epub 2008 Dec 4.
3
Preventive effects of fasudil on adriamycin-induced cardiomyopathy: possible involvement of inhibition of RhoA/ROCK pathway.法舒地尔对阿霉素诱导性心肌病的预防作用:可能涉及抑制 RhoA/ROCK 通路。
Food Chem Toxicol. 2011 Nov;49(11):2975-82. doi: 10.1016/j.fct.2011.06.080. Epub 2011 Jul 22.
4
Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts.盐酸法舒地尔水合物,一种 Rho 激酶抑制剂,可抑制高糖诱导的大鼠心肌成纤维细胞增殖和胶原合成。
Clin Exp Pharmacol Physiol. 2011 Jun;38(6):387-94. doi: 10.1111/j.1440-1681.2011.05523.x.
5
Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.法舒地尔通过抑制 Rho 激酶抑制脂多糖诱导的大鼠肺微血管内皮细胞凋亡通过 JNK 和 p38MAPK 通路。
Biomed Pharmacother. 2014 Apr;68(3):267-75. doi: 10.1016/j.biopha.2013.12.003. Epub 2013 Dec 24.
6
RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism.RhoA/ROCK可能参与实验性甲状腺功能亢进诱导的心肌肥大。
Toxicol Ind Health. 2012 Oct;28(9):831-9. doi: 10.1177/0748233711425069. Epub 2011 Nov 9.
7
Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.盐酸法舒地尔水合物,一种Rho激酶(ROCK)抑制剂,可抑制肝星状细胞中的胶原蛋白生成并增强胶原酶活性。
Liver Int. 2005 Aug;25(4):829-38. doi: 10.1111/j.1478-3231.2005.01142.x.
8
The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.Rho激酶抑制剂法舒地尔通过改善钙清除和肌动蛋白重塑来减轻糖尿病引起的心脏功能障碍。
J Mol Med (Berl). 2017 Feb;95(2):155-165. doi: 10.1007/s00109-016-1469-1. Epub 2016 Aug 30.
9
Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.Rho激酶抑制对大鼠实验性心肌梗死后心肌重塑和收缩功能的有益作用机制。
Ther Adv Cardiovasc Dis. 2016 Feb;10(1):4-20. doi: 10.1177/1753944715609516. Epub 2015 Oct 21.
10
Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.法舒地尔抑制Rho激酶可改善糖尿病引起的微血管损伤。
Diabetes. 2009 Jan;58(1):215-26. doi: 10.2337/db08-0762. Epub 2008 Oct 7.

引用本文的文献

1
Serum Pharmacochemistry Combined with Network Pharmacology-Based Mechanism Prediction and Pharmacological Validation of Zhenwu Decoction on Alleviating Isoprenaline-Induced Heart Failure Injury in Rats.基于血清药物化学结合网络药理学预测真武汤减轻异丙肾上腺素诱导的大鼠心力衰竭损伤作用机制及药效验证
ACS Omega. 2023 Sep 28;8(40):37233-37247. doi: 10.1021/acsomega.3c05055. eCollection 2023 Oct 10.
2
Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway.Szeto-Schiller 肽 31 通过抑制 p38 MAPK 信号通路的激活来改善阿霉素诱导的心脏毒性。
Int J Mol Med. 2021 Apr;47(4). doi: 10.3892/ijmm.2021.4896. Epub 2021 Mar 2.
3
D-Limonene mitigate myocardial injury in rats through MAPK/ERK/NF-κB pathway inhibition.
D-柠檬烯通过抑制MAPK/ERK/NF-κB信号通路减轻大鼠心肌损伤。
Korean J Physiol Pharmacol. 2020 May 1;24(3):259-266. doi: 10.4196/kjpp.2020.24.3.259.
4
Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway.美托洛尔和比索洛尔通过蛋白激酶C/核因子κB/原癌基因c-fos信号通路改善高糖诱导的新生大鼠心肌细胞肥大。
Exp Ther Med. 2020 Feb;19(2):871-882. doi: 10.3892/etm.2019.8312. Epub 2019 Dec 10.
5
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients.Rho激酶活性、连接蛋白40与心房颤动:来自透析终末期肾病患者的机制性见解
J Clin Med. 2020 Jan 7;9(1):165. doi: 10.3390/jcm9010165.
6
Ginsenoside Re Improves Isoproterenol-Induced Myocardial Fibrosis and Heart Failure in Rats.人参皂苷Re改善异丙肾上腺素诱导的大鼠心肌纤维化和心力衰竭
Evid Based Complement Alternat Med. 2019 Jan 1;2019:3714508. doi: 10.1155/2019/3714508. eCollection 2019.
7
Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension.肺动脉高压的新型治疗靶点的鉴定。
Int J Mol Sci. 2018 Dec 17;19(12):4081. doi: 10.3390/ijms19124081.
8
Rho kinase signaling and cardiac physiology.Rho激酶信号传导与心脏生理学
Curr Opin Physiol. 2018 Feb;1:14-20. doi: 10.1016/j.cophys.2017.07.005. Epub 2017 Dec 13.
9
inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun.通过靶向 c-Jun 抑制异丙肾上腺素诱导的心肌肥厚。
Biosci Rep. 2018 Mar 9;38(2). doi: 10.1042/BSR20171430. Print 2018 Apr 27.
10
JNK and NF-κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure.JNK和NF-κB信号通路参与先天性心脏病患者经导管封堵术前和术后的细胞因子变化。
Exp Ther Med. 2018 Feb;15(2):1525-1531. doi: 10.3892/etm.2017.5595. Epub 2017 Dec 5.